SCRIP Awards 2013 -Best Company in an Emerging Market – Dr Reddy’s Laboratories – India, Novartis’s Bexsero, Best New Drug « New Drug Approvals

SCRIP Awards 2013 -Best Company in an Emerging Market – Dr Reddy’s Laboratories – India, Novartis’s Bexsero, Best New Drug « New Drug Approvals:

'via Blog this'

Bayer, Onyx win early FDA OK for Nexavar (sorafenib) in thyroid cancer « New Drug Approvals

Bayer, Onyx win early FDA OK for Nexavar (sorafenib) in thyroid cancer « New Drug Approvals:

'via Blog this'

Otsuka and Lundbeck’s Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe « New Drug Approvals

Otsuka and Lundbeck’s Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe « New Drug Approvals:

'via Blog this'

DAGLUTRIL » All About Drugs

DAGLUTRIL » All About Drugs:

'via Blog this'

ANDARINE, Male drugs » All About Drugs

ANDARINE, Male drugs » All About Drugs:

'via Blog this'

SCRIP Awards 2013 -Best Company in an Emerging Market – Dr Reddy’s Laboratories – India, Novartis’s Bexsero, Best New Drug « New Drug Approvals

SCRIP Awards 2013 -Best Company in an Emerging Market – Dr Reddy’s Laboratories – India, Novartis’s Bexsero, Best New Drug « New Drug Approvals:

'via Blog this'

Late-stage success for Sanofi/Regeneron RA drug sarilumab « New Drug Approvals

Late-stage success for Sanofi/Regeneron RA drug sarilumab « New Drug Approvals:

'via Blog this'